MedTrace Logo

Grastion and Percussion Therapy

NCT07389395 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-02-05

No results posted yet for this study

Summary

The study aims to investigate the effects of percussion therapy and instrument-assisted soft tissue mobilization (AISM), commonly used in clinical settings, on muscle fatigue, maximum muscle strength, pain threshold, and muscle oxygenation.

The study will involve 20 volunteer participants. To achieve the study results, pre-exercise percussion therapy and instrument-assisted soft tissue mobilization (AISM) will be administered using a crossover design.

Results will be measured using a digital dynamometer, a moxy oxygen monitor, and a fatigue questionnaire.

Conditions

  • Muscle Fatigue and Muscle Oxygenation

Interventions

OTHER

Percussion Therapy

The massage gun will operate at a frequency of 30 beats per second (30 Hz), and percussion therapy will be applied to the muscle for 2 minutes. Percussion therapy will be performed using the device's standard ball head. The force applied by the device will be fixed so that it does not exceed the device's first-stage force setting (approximately 30 pounds). The biceps brachii (dominant arm) will be treated for 2 minutes at 30 Hz, moderate intensity.

OTHER

Instrument-Assisted Soft Tissue Mobilization (AISM)

The arm will be positioned at the edge of the bed in full extension, with the shoulder in 45-degree abduction. The examiner will apply gentle pressure using a 30-degree angled instrument at a rate of 120 strokes/min, aligning the instrument's weight with the fibers of the biceps brachii muscle. The examiner will use a metronome to maintain a consistent pace during treatment, and the instrument angle will be calibrated with a protractor before each subject's treatment. The procedure will last 2 minutes, and baby oil will be used to ensure the instrument moves smoothly over the skin.

Sponsors & Collaborators

  • Karabuk University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-02-15
Primary Completion
2026-04-01
Completion
2026-06-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07389395 on ClinicalTrials.gov